EQRX — EQRx Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.14bn
- -$71.09m
Annual cashflow statement for EQRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -8.51 | -250 | -100 | -169 |
| Depreciation | ||||
| Non-Cash Items | 3.88 | 0.568 | -69.2 | -130 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 2.02 | 7.57 | -15.1 | 10.9 |
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -2.6 | -242 | -183 | -287 |
| Capital Expenditures | -0.078 | -2.98 | -0.448 | -1.13 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | -4 | -896 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -0.078 | -2.98 | -4.45 | -897 |
| Financing Cash Flow Items | — | — | 1,305 | -1.36 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 22 | 715 | 1,376 | 0.139 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 19.3 | 471 | 1,189 | -1,184 |